Drugs that contain Levetiracetam

1. List of Elepsia Xr drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8535717 TRIPOINT Pharmaceutical composition
Feb, 2026

(3 years from now)

US8425938 TRIPOINT Pharmaceutical composition
Feb, 2026

(3 years from now)

US8163306 TRIPOINT Oral drug delivery system
Sep, 2027

(4 years from now)

US8431156 TRIPOINT Pharmaceutical composition
Oct, 2027

(4 years from now)

US8470367 TRIPOINT Oral drug delivery system
Oct, 2027

(4 years from now)

Market Authorisation Date: 20 December, 2018

Treatment: NA

Dosage: TABLET, EXTENDED RELEASE;ORAL

More Information on Dosage

2. List of Keppra drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8802142 UCB INC Pharmaceutical compositions comprising levetiracetam and process for their preparation
Jun, 2031

(8 years from now)

US8802142

(Pediatric)

UCB INC Pharmaceutical compositions comprising levetiracetam and process for their preparation
Dec, 2031

(8 years from now)

Market Authorisation Date: 30 November, 1999

Treatment: NA

Dosage: TABLET;ORAL

How can I launch a generic of KEPPRA before it's patent expiration?
More Information on Dosage

3. List of Keppra Xr drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7858122 UCB INC Extended release formulation of levetiracetam
Sep, 2028

(5 years from now)

Market Authorisation Date: 12 September, 2008

Treatment: NA

Dosage: TABLET, EXTENDED RELEASE;ORAL

How can I launch a generic of KEPPRA XR before it's patent expiration?
More Information on Dosage

4. List of Spritam drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9339489 APRECIA PHARMS Rapid disperse dosage form containing levetiracetam
Mar, 2034

(11 years from now)

US9669009 APRECIA PHARMS Rapid disperse dosage form containing levetiracetam
Mar, 2034

(11 years from now)

US11160786 APRECIA PHARMS Rapid disperse dosage form
Mar, 2034

(11 years from now)

Market Authorisation Date: 31 July, 2015

Treatment: Method of administering levetiracetam; Method of administering levetiracetam under fasted conditions; Method of administering levetiracetam under fed conditions

Dosage: TABLET, FOR SUSPENSION;ORAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic